MS 7 – Targeting 2018-09-26T15:27:03+00:00

Targeting the hematoma in intracerebral hemorrhage

Tuesday, 09.10.2018 | 01:30 – 03:00 pm

01:30 –
01:50 pm
Marietta Zille
(Luebeck, Germany)
Cell type-specific mechanisms of hematoma toxicity in intracerebral hemorrhage
01:50 –
02:10 pm
Saravanan S. Karuppagounder
(White Plains, United States)
Therapeutic targeting of nuclear derived toxic lipids after intracerebral hemorrhage
02:10 –
02:35 pm
Daniel F. Hanley
(Baltimore, MD, United States)
MISTIE III: Results explain perihematomal edema
02:35 –
03:00 pm
Lauren H. Sansing
(New Haven, United States)
Interrogation of human immune responses after intracerebral hemorrhage